ShareSoc Growth Company Seminar, London, April 2016

Click here for 1PM Stockopedia Report Click here for ShareSoc Improving AIM Report Click here Immupharma Stockopedia Report

Leaders and Laggards

Laggard Hugely Disappointing That ImmuPharma Excludes Individuals From Placing

I have been an investor, supporter and follower of ImmuPharma. So I was appalled to read that ImmuPharma (LSE:IMM) has raised £6.5 million, before expenses, via an oversubscribed placing of 59,090,909 new ordinary shares at a price of 11p per share. There was no Primary Bid offer and no notification to investors who hold their shares via nominee of this placing nor any invitation for them to share in the spoils. The placing was at 11p and the share price this morning ...